Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Croft

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The British Journal of Ophthalmology|February 13, 2014
Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial)Charles C Wykoff, David M Brown, Maria E Maldonado, et al.
Retina (Philadelphia, Pa.)|August 8, 2014
Progressive retinal nonperfusion in ischemic central retinal vein occlusionCharles C Wykoff, David M Brown, Daniel E Croft, et al.
Retina (Philadelphia, Pa.)|June 15, 2013
Comparison of spectral-domain and time-domain optical coherence tomography in the detection of neovascular age-related macular degeneration activityJames C Major, Charles C Wykoff, Angeline F Mariani, et al.
Ophthalmology|January 17, 2018
Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE TrialDavid M Brown, William C Ou, Tien P Wong, et al.
Retina (Philadelphia, Pa.)|June 11, 2014
Ranibizumab in preproliferative (ischemic) central retinal vein occlusion: the rubeosis anti-VEGF (RAVE) trialDavid M Brown, Charles C Wykoff, Tien P Wong, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 2011
Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individualsAri D Kalechstein, Jin H Yoon, Daniel E Croft, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|July 19, 2014
Precise montaging and metric quantification of retinal surface area from ultra-widefield fundus photography and fluorescein angiographyDaniel E Croft, Jano van Hemert, Charles C Wykoff, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 21, 2013
SAVE (Super-dose anti-VEGF) trial: 2.0 mg ranibizumab for recalcitrant neovascular age-related macular degeneration: 1-year resultsCharles C Wykoff, David M Brown, Eric Chen, et al.
Retinal Cases & Brief Reports|November 20, 2015
CHOROIDAL NEOVASCULARIZATION SECONDARY TO ALEXANDRITE LASER EXPOSURERui Wang, Charles C Wykoff, Lynsey Christie, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|October 13, 2015
Aflibercept for pigment epithelial detachment for previously treated neovascular age-related macular degenerationJames C Major, Charles C Wykoff, Daniel E Croft, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The British Journal of Ophthalmology|February 13, 2014
Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial)Charles C Wykoff, David M Brown, Maria E Maldonado, et al.
Retina (Philadelphia, Pa.)|August 8, 2014
Progressive retinal nonperfusion in ischemic central retinal vein occlusionCharles C Wykoff, David M Brown, Daniel E Croft, et al.
Retina (Philadelphia, Pa.)|June 15, 2013
Comparison of spectral-domain and time-domain optical coherence tomography in the detection of neovascular age-related macular degeneration activityJames C Major, Charles C Wykoff, Angeline F Mariani, et al.
Ophthalmology|January 17, 2018
Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE TrialDavid M Brown, William C Ou, Tien P Wong, et al.
Retina (Philadelphia, Pa.)|June 11, 2014
Ranibizumab in preproliferative (ischemic) central retinal vein occlusion: the rubeosis anti-VEGF (RAVE) trialDavid M Brown, Charles C Wykoff, Tien P Wong, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 2011
Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individualsAri D Kalechstein, Jin H Yoon, Daniel E Croft, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|July 19, 2014
Precise montaging and metric quantification of retinal surface area from ultra-widefield fundus photography and fluorescein angiographyDaniel E Croft, Jano van Hemert, Charles C Wykoff, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 21, 2013
SAVE (Super-dose anti-VEGF) trial: 2.0 mg ranibizumab for recalcitrant neovascular age-related macular degeneration: 1-year resultsCharles C Wykoff, David M Brown, Eric Chen, et al.
Retinal Cases & Brief Reports|November 20, 2015
CHOROIDAL NEOVASCULARIZATION SECONDARY TO ALEXANDRITE LASER EXPOSURERui Wang, Charles C Wykoff, Lynsey Christie, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|October 13, 2015
Aflibercept for pigment epithelial detachment for previously treated neovascular age-related macular degenerationJames C Major, Charles C Wykoff, Daniel E Croft, et al.
Pageof 2